| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.36 | 0.03 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.32 | 0.1 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.31 | 0.04 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.2 | 0.3 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.2 | 0.3 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.1 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.17 | 8e-07 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.16 | 0.6 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.003 |